Γιώργος Μίλεσης, MSc Κλινικός Διαιτολόγος

  1. Yoshino J, Mills KF, Yoon MJ, and S Imai. Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice. Cell Metabolism, October 2011; 14 (4):528–36
  2. Imai S and J Yoshino. The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing (review article)Diabetes, Obesity and Metabolism 2013; 15 (Suppl. 3): 26– 33
  3. Mills KF, et al. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in MiceCell Metabolism, October 2016; DOI: 10.1016/j.cmet.2016.09.013
  4. Stromsdorfer KL, Yamaguchi S, Yoon MJ, Moseley AC, Franczyk MP, Kelly SC, Qi N, Imai S, and J Yoshino. NAMPT-Mediated NAD+ Biosynthesis in Adipocytes Regulates Adipose Tissue Function and Multi-organ Insulin Sensitivity in MiceCells Reports, August 2016; 16 (7): 1851-60